r.coelho
TL2 Moderator · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 8 September 2025 · last posted 16h
98 posts, newest first. Showing up to 150.
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #14 · Nutrition & Training › Protein & intake · 27 Jul 2026 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #112 · Access › International · 26 Jul 2026 · 0 likes Picking up post #109: that is the part I would want checked first. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
Here for the analytics and not much else Replied, post #96 · Lounge › Introductions · 26 Jul 2026 · 0 likes Coming back to post #94, because the follow-up matters more than the original answer. Community culture: introductions give you a sense of who is here. Reading a few…
-
What a certificate commits its issuer to Replied, post #106 · Analytics › COA interpretation · 26 Jul 2026 · 30 likes I read post #104 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #85 · Compounds › Retatrutide · 23 Jul 2026 · 18 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #51 · Sourcing › Regulatory · 21 Jul 2026 · 7 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Athletes in weight-category sports: a different risk calculus Replied, post #32 · Clinical › Special populations · 19 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #49 · Research Methods › Statistics · 19 Jul 2026 · 0 likes Picking up post #46: that is the part I would want checked first. Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A…
-
Insurance and replacement policies, compared Replied, post #100 · Sourcing › Logistics · 19 Jul 2026 · 10 likes post #99 is right about the mechanism and I think understates the practical bit. Declaring contents accurately: declaring accurately reduces intervention risk. A…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #124 · Evidence › Journal club · 18 Jul 2026 · 5 likes On post #120 — agreed on the reasoning, with one qualification. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
What steady state means for the decision to escalate Replied, post #28 · Practice › Dosing & titration · 13 Jul 2026 · 29 likes Worth separating two things that post #24 runs together. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
Research-use-only status: what it means legally and practically Replied, post #73 · Compounds › Other compounds · 11 Jul 2026 · 27 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #41 · Analytics › Impurities & related substances · 2 Jul 2026 · 1 like Worth separating two things that post #37 runs together. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A…
-
Tracking a shortage from primary sources rather than rumour Replied, post #63 · Access › Shortages · 22 Jun 2026 · 25 likes On post #59 — agreed on the reasoning, with one qualification. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #82 · Data & Tools › Datasets · 18 Jun 2026 · 6 likes On post #78 — agreed on the reasoning, with one qualification. Community-collected datasets: some members have compiled datasets from their own experience and shared…
-
Pooling trials with different estimands Replied, post #30 · Evidence › Meta-analyses · 17 Jun 2026 · 2 likes On post #26 — agreed on the reasoning, with one qualification. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Electrolyte supplements: which ones do anything Replied, post #31 · Nutrition & Training › Hydration & electrolytes · 15 Jun 2026 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #24 · Practice › Reconstitution · 7 Jun 2026 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL.…
-
Pooling trials with different estimands Started this topic · Evidence › Meta-analyses · 30 May 2026 · 34 likes On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med , 2023) with SURMOUNT-1 ( N…
-
Injection volume, overload, and peak distortion Replied, post #26 · Analytics › HPLC & UHPLC · 29 May 2026 · 16 likes Coming back to post #24, because the follow-up matters more than the original answer. Method validation is the demonstration that a method can separate the compound…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #85 · Compounds › Tirzepatide · 24 May 2026 · 11 likes I read post #83 twice before replying, because I had assumed the opposite. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
-
Request: a per-category review queue Replied, post #3 · Meta › Feature requests · 24 May 2026 · 5 likes Coming back to the opening post, because the follow-up matters more than the original answer. Requests for platform and documentation features, with the reasoning that…
-
The headache that turns out to be dehydration — the long version Replied, post #34 · Nutrition & Training › Hydration & electrolytes · 12 May 2026 · 0 likes post #33 is right about the mechanism and I think understates the practical bit. Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals…
-
Requesting a translation of an existing page — the long version Replied, post #7 · Documentation › Wiki requests · 8 May 2026 · 3 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #4 · Start Here › How to Ask · 6 May 2026 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #92 · Clinical › Bloodwork · 5 May 2026 · 28 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
The "under review" status pill and when a moderator applies it Replied, post #112 · Evidence › Preprints · 3 May 2026 · 18 likes Coming back to post #110, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #76 · Evidence › Trials · 19 Apr 2026 · 8 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Sample handling between despatch and injection Replied, post #46 · Analytics › Method validation · 17 Apr 2026 · 3 likes Picking up post #43: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #9 · Devices › Syringes & needles · 6 Apr 2026 · 27 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #71 · Clinical › Bloodwork · 27 Mar 2026 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #12 · Evidence › Journal club · 21 Mar 2026 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Whether protein timing matters at a large deficit Replied, post #34 · Nutrition & Training › Protein & intake · 15 Mar 2026 · 1 like This follows post #31 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #140 · Compounds › Semaglutide · 10 Mar 2026 · 7 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Choosing which test to pay for, given a fixed budget Replied, post #19 · Sourcing › Independent verification · 10 Mar 2026 · 2 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #70 · Evidence › Study critique · 20 Feb 2026 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #59 · Meta › Site feedback · 31 Jan 2026 · 9 likes post #58 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Choosing a concentration on purpose rather than by accident Started this topic · Practice › Reconstitution · 27 Jan 2026 · 4 likes Second pass at: Choosing a concentration on purpose rather than by accident Writing it up because I had to work it out twice and would rather nobody else did. A…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #67 · Access › International · 21 Jan 2026 · 0 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #47 · Sourcing › Regulatory · 6 Jan 2026 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Preprint servers and what screening they do Replied, post #12 · Evidence › Preprints · 31 Dec 2025 · 28 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #62 · Practice › Side effects · 28 Dec 2025 · 11 likes Coming back to post #60, because the follow-up matters more than the original answer. Gallbladder complications: rapid weight loss increases the risk of gallstone…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #120 · Practice › Reconstitution · 15 Dec 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tracking a preprint to publication: a worked example Replied, post #32 · Evidence › Preprints · 2 Dec 2025 · 19 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Why "add 2 mL" is not an instruction Replied, post #13 · Practice › Reconstitution · 1 Dec 2025 · 29 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
History of disordered eating and why it changes the conversation Replied, post #25 · Clinical › Special populations · 1 Dec 2025 · 1 like Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
What a purity-only report leaves out Replied, post #92 · Sourcing › Independent verification · 18 Nov 2025 · 15 likes Picking up post #89: that is the part I would want checked first. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest…
-
[2026 update] What steady state means for the decision to escalate Replied, post #17 · Practice › Dosing & titration · 6 Nov 2025 · 5 likes post #16 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
What a purity-only report leaves out Replied, post #71 · Sourcing › Independent verification · 3 Nov 2025 · 28 likes Worth separating two things that post #67 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #75 · Safety › Adverse events · 31 Oct 2025 · 1 like Coming back to post #73, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #109 · Practice › Storage & stability · 29 Oct 2025 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
A 40-week log with the measurement method stated Replied, post #68 · Outcomes › Progress reports · 25 Oct 2025 · 2 likes I read post #66 twice before replying, because I had assumed the opposite. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability…
-
Documentation that appears only after payment Replied, post #57 · Sourcing › Red flags · 24 Oct 2025 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #17 · Clinical › Special populations · 22 Oct 2025 · 3 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
High-resolution MS on aggregates and what it can see Replied, post #99 · Analytics › Mass spectrometry · 21 Oct 2025 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to read a forest plot, properly, from scratch Replied, post #42 · Evidence › Trials · 18 Oct 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Micronutrient adequacy at low total intake — does this still hold? Started this topic · Nutrition & Training › Protein & intake · 2 Oct 2025 · 6 likes Micronutrient adequacy at low total intake — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Longitudinal…
-
Managing an unplanned gap in supply — what changed since Replied, post #67 · Access › Shortages · 20 Sep 2025 · 7 likes This follows post #64 rather than contradicting it. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #70 · Practice › Administration · 20 Sep 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Payment method and the leverage it gives you, ranked Replied, post #29 · Sourcing › Payments · 18 Sep 2025 · 10 likes Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
-
Thyroid function tests during substantial weight change Replied, post #57 · Clinical › Bloodwork · 10 Sep 2025 · 28 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #38 · Analytics › Method validation · 8 Sep 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Realistic expectations for strength while losing weight quickly Replied, post #19 · Nutrition & Training › Resistance training · 7 Sep 2025 · 0 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #111 · Practice › Reconstitution · 23 Aug 2025 · 15 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Follow-up: Why appetite effects are mostly central Replied, post #22 · Pharmacology › Receptor biology · 21 Aug 2025 · 2 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #8 · Start Here › How to Ask · 18 Aug 2025 · 6 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #7 · Sourcing › Regulatory · 11 Aug 2025 · 2 likes Picking up post #4: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
A request that was declined, and the reasoning — a second dataset Replied, post #35 · Documentation › Wiki requests · 9 Aug 2025 · 20 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Canadian access and provincial variation — one year on Replied, post #47 · Regional › North America · 29 Jul 2025 · 31 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #9 · Compounds › Secretagogues & GH axis · 24 Jul 2025 · 3 likes Coming back to post #7, because the follow-up matters more than the original answer. Ipamorelin selectivity claims originate in preclinical characterisation and are…
-
The storage lookup and where its data comes from Replied, post #3 · Data & Tools › Calculators · 10 Jun 2025 · 1 like Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #17 · Clinical › Special populations · 1 Jun 2025 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #123 · Compounds › Cagrilintide & amylin analogues · 27 May 2025 · 0 likes Picking up post #120: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #76 · Sourcing › Independent verification · 10 May 2025 · 0 likes Coming back to post #74, because the follow-up matters more than the original answer. Cost and turnaround: different services have different pricing and turnaround…
-
Deamidation and the close-eluting pair it produces Replied, post #31 · Analytics › Impurities & related substances · 24 Apr 2025 · 0 likes This follows post #28 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: Requesting a page: what makes a good request Replied, post #18 · Documentation › Wiki requests · 5 Apr 2025 · 0 likes Picking up post #15: that is the part I would want checked first. Cross-referencing: if you notice two pages that should reference each other but do not, suggest the…
-
A well-designed study with a badly written abstract Started this topic · Evidence › Study critique · 27 Mar 2025 · 26 likes Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Comparing SCALE ( N Engl J…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #9 · Evidence › Journal club · 12 Mar 2025 · 15 likes Picking up post #6: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #112 · Compounds › Semaglutide · 21 Feb 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #3 · Evidence › Journal club · 19 Feb 2025 · 3 likes Picking up post #2: that is the part I would want checked first. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #54 · Sourcing › Red flags · 18 Feb 2025 · 4 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
UK access routes, dated and sourced — a second dataset Replied, post #35 · Regional › UK & Ireland · 5 Feb 2025 · 2 likes On post #31 — agreed on the reasoning, with one qualification. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss…
-
What we do not know about retatrutide, listed explicitly Replied, post #70 · Compounds › Retatrutide · 26 Jan 2025 · 10 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #47 · Compounds › Oral incretins · 13 Jan 2025 · 3 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #96 · Compounds › Semaglutide · 24 Dec 2024 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #49 · Evidence › Trials · 21 Dec 2024 · 0 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Washout with a one-week half-life: the arithmetic Replied, post #23 · Research Methods › N-of-1 designs · 26 Nov 2024 · 13 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #70 · Devices › Syringes & needles · 23 Nov 2024 · 0 likes Picking up post #67: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #5 · Practice › Reconstitution · 23 Nov 2024 · 24 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #11 · Practice › Reconstitution · 11 Nov 2024 · 9 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
US compounding rules and how they changed Replied, post #60 · Regional › North America · 6 Nov 2024 · 10 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
Time to steady state after a dose increase Replied, post #94 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes This follows post #91 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #23 · Evidence › Journal club · 3 Nov 2024 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Why I ask for the gradient before I discuss the number Replied, post #19 · Analytics › HPLC & UHPLC · 10 Sep 2024 · 5 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #32 · Analytics › Mass spectrometry · 16 Aug 2024 · 27 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #110 · Compounds › Retatrutide · 23 Jul 2024 · 0 likes Coming back to post #108, because the follow-up matters more than the original answer. Retatrutide is investigational. Anything obtained outside a trial is by…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #82 · Compounds › Retatrutide · 21 Jul 2024 · 1 like Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Journal club: FLOW and the renal composite, component by component Replied, post #80 · Evidence › Journal club · 17 Jul 2024 · 4 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…